ORIC Pharmaceuticals, Inc. (ORIC)

ORIC Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,048	569	502	265	579	1,240
Market Cap Growth	81.47%	13.47%	89.55%	-54.26%	-53.31%	-
Enterprise Value	772	307	285	84	302	1,053
Last Close Price	10.77	8.07	9.20	5.89	14.70	33.85
PB Ratio	2.86	2.34	2.24	1.19	2.12	4.28
P/TBV Ratio	3.23	2.34	2.24	1.19	2.12	4.28
Debt / Equity Ratio	0.03	0.04	0.05	0.05	0.05	-
Quick Ratio	15.65	10.30	10.18	13.41	15.64	32.62
Current Ratio	16.13	10.56	10.39	13.68	15.88	32.96
Return on Equity (ROE)	-43.82%	-54.73%	-45.11%	-35.98%	-27.98%	-39.02%
Return on Assets (ROA)	-27.68%	-33.95%	-27.74%	-19.87%	-16.50%	-15.69%
Return on Capital (ROIC)	-29.04%	-36.69%	-29.54%	-20.86%	-17.14%	-16.33%
Earnings Yield	-13.12%	-22.45%	-20.06%	-33.66%	-13.60%	-5.94%
FCF Yield	-11.60%	-19.99%	-17.24%	-29.17%	-10.45%	-3.70%
Buyback Yield / Dilution	-14.90%	-35.52%	-29.74%	-4.48%	-72.97%	-1055.26%

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q